Öğüt, T. S. Et Al. 2023. Neuropathic pain in axial spondyloarthropathy is underdiagnosed and a confounding factor in biologic drug–switching decision: a cross-sectional study. Clinical Rheumatology , vol.42, no.5 , 1275-1284.

Öğüt, T. S., ERBASAN, F., TERZİOĞLU, M., Aslan, B., Çelik, E., & YAZISIZ, V., (2023). Neuropathic pain in axial spondyloarthropathy is underdiagnosed and a confounding factor in biologic drug–switching decision: a cross-sectional study. Clinical Rheumatology , vol.42, no.5, 1275-1284.

Öğüt, Tahir Et Al. "Neuropathic pain in axial spondyloarthropathy is underdiagnosed and a confounding factor in biologic drug–switching decision: a cross-sectional study," Clinical Rheumatology , vol.42, no.5, 1275-1284, 2023

Öğüt, Tahir S. Et Al. "Neuropathic pain in axial spondyloarthropathy is underdiagnosed and a confounding factor in biologic drug–switching decision: a cross-sectional study." Clinical Rheumatology , vol.42, no.5, pp.1275-1284, 2023

Öğüt, T. S. Et Al. (2023) . "Neuropathic pain in axial spondyloarthropathy is underdiagnosed and a confounding factor in biologic drug–switching decision: a cross-sectional study." Clinical Rheumatology , vol.42, no.5, pp.1275-1284.

@article{article, author={Tahir S. Öğüt Et Al. }, title={Neuropathic pain in axial spondyloarthropathy is underdiagnosed and a confounding factor in biologic drug–switching decision: a cross-sectional study}, journal={Clinical Rheumatology}, year=2023, pages={1275-1284} }